The U.S. life sciences industry entered 2026 with surprising momentum, following threats of tariffs and disrupted trade, NIH funding cuts, and a sluggish IPO market. Accounting for more than ...

The landscape for the life sciences industry is changing. The COVID-19 pandemic, Brexit and the increasingly volatile geopolitical situation relating to the war in Ukraine are influencing the ability ...

If anybody knows about the importance of a patient-centric approach to life sciences, it is Sharon Suchotliff. As Associate Principal of Patient Centricity at ZS and co-author of Reinventing Patient ...